Feng-Cai Zhu

Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology

Nanjing

China

SCHOLARLY PAPERS

8

DOWNLOADS

1,701

SSRN CITATIONS

8

CROSSREF CITATIONS

0

Scholarly Papers (8)

1.

Immunogenicity and Safety of BNT162b2 mRNA Vaccine in Chinese Adults: A Randomized Clinical Trial

Number of pages: 35 Posted: 19 May 2022
Fosun Pharma (USA), Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Taizhou People’s Hospital, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Taizhou Vaccine Clinical Research Center, Taizhou People’s Hospital, Fosun Pharma (China), Fosun Pharma (China), Taizhou Vaccine Clinical Research Center, Taizhou People’s Hospital, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Lianshui Center for Disease Control and Prevention, Lianshui Center for Disease Control and Prevention, Fosun Pharma (China), Fosun Pharma (China), Fosun Pharma (China), BioNTech (Germany), BioNTech (Germany), BioNTech (USA), Fosun Pharma (China), BioNTech (Germany), BioNTech (Germany), BioNTech (Germany), BioNTech (Germany), BioNTech (USA), BioNTech (USA), BioNTech (Germany), BioNTech (Germany), BioNTech (Germany) and Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology
Downloads 541 (96,652)
Citation 1

Abstract:

Loading...

BNT162b2 mRNA vaccine, COVID-19, intramuscular injection, messenger RNA, neutralizing antibodies, SARS-CoV-2, vaccination

2.

Safety and Immunogenicity of Heterologous Boost Immunisation With an Aerosolized Ad5-nCoV After Two-Dose Priming With an Inactivated SARS-CoV-2 Vaccine CoronaVac in Adults: A Randomised, Open-Label, Parallel-Control Trial

Number of pages: 26 Posted: 04 Jan 2022
Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Academy of Military Medical Sciences - Institute of Biotechnology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Collaborative Innovation Center for Diagnosis Treatment of Infectious Diseases - NHC Key Laboratory of Biosafety, Donghai County Center for Disease Control and Prevention, CanSino Biologics Inc., Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Academy of Military Medical Sciences - Institute of Biotechnology, CanSino Biologics Inc., Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, CanSino Biologics Inc., Donghai County Center for Disease Control and Prevention, CanSino Biologics Inc., Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, CanSino Biologics Inc., Nanjing Vazyme Biotech Co., Ltd., Nanjing Medical University - School of Public Health, Southeast University - School of Public Health, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, CanSino Biologics Inc., Collaborative Innovation Center for Diagnosis Treatment of Infectious Diseases - NHC Key Laboratory of Biosafety, Academy of Military Medical Sciences - Institute of Biotechnology and Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology
Downloads 452 (120,034)
Citation 1

Abstract:

Loading...

Heterologous boost, aerosolized adenovirus type-5 vector-based COVID-19 vaccine, safety, immunogenicity, inactivated COVID-19 vaccine, clinical trial

3.

Safety, Immunogenicity and Efficacy of the mRNA Vaccine CS-2034 as a Heterologous Booster Versus Homologous Booster with BBIBP-CorV in Adults Aged ≥18 Years: A Randomized, Partial-Blind, Phase 2b Trial

Number of pages: 25 Posted: 15 Feb 2023
Yixing People's Hospital, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, CanSino Biologics Inc., CanSino Biologics Inc., Yixing People's Hospital, CanSino Biologics Inc., CanSino Biologics Inc., Yixing People's Hospital, Yixing People's Hospital, CanSino Biologics Inc., Yixing People's Hospital, CanSino Biologics Inc., CanSino Biologics Inc., CanSino Biologics Inc., CanSino Biologics Inc., Guangzhou Laboratory, CanSino Biologics Inc., CanSino Biologics Inc., CanSino Biologics Inc., Guangzhou Medical University - State Key Laboratory of Respiratory Disease and Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology
Downloads 192 (291,402)

Abstract:

Loading...

SARS-CoV-2, Omicron, heterologous booster, homologous booster, mRNA vaccine CS-2034, safety, immunogenicity

4.

Safety, Tolerability and Immunogenicity of a Recombinant Adenovirus Type 5 Vectored COVID-19 Vaccine in Healthy Adults in China: Preliminary Report of a First-In Human Single-Center, Open-Label, Dose-Escalating Clinical Trial

Number of pages: 21 Posted: 17 Jun 2020
Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Independent, Independent, Independent, Independent, Collaborative Innovation Center for Diagnosis Treatment of Infectious Diseases - Jiangsu Provincial Center for Disease Control and Prevention, Independent, Independent, Independent, Independent, Independent, Independent, Independent, Independent, Independent, Independent, Huazhong University of Science and Technology - Department of Neurology, Independent, Independent, Huazhong University of Science and Technology - Department of Neurology and Academy of Military Medical Sciences - Institute of Biotechnology
Downloads 134 (394,279)
Citation 7

Abstract:

Loading...

COVID-19; Vaccine; SARS-CoV-2; Clinical trial

5.

Safety and Immunogenicity of Aerosolised Ad5-nCoV or Intramuscular Ad5-nCoV or Inactivated COVID-19 Vaccine Coronavac Given as the Second Booster Following Three Doses of CoronaVac: A Multicentre, Open-Label, Phase 4, Randomized Trial

Number of pages: 24 Posted: 30 Dec 2022
Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Southeast University - School of Public Health, Academy of Military Medical Sciences - Institute of Biotechnology, CanSino Biologics Inc., Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Donghai County Center for Disease Control and Prevention, CanSino Biologics Inc., Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Academy of Military Medical Sciences - Institute of Biotechnology, CanSino Biologics Inc., Donghai County Center for Disease Control and Prevention, CanSino Biologics Inc., Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Lianshui Center for Disease Control and Prevention, CanSino Biologics Inc., Nanjing Vazyme Biotech Co., Ltd., Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Nanjing Medical University - School of Public Health, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Southeast University - School of Public Health, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Lianshui Center for Disease Control and Prevention, CanSino Biologics Inc., Academy of Military Medical Sciences - Institute of Biotechnology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology and Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology
Downloads 118 (434,241)

Abstract:

Loading...

6.

Safety, Immunogenicity and Efficacy of Heterologous Boost with an Aerosolized Ad5-nCoV after Two-Dose Priming with Inactivated COVID-19 Vaccines in Adults: A Multicenter, Open-Label Trial

Number of pages: 25 Posted: 07 Apr 2023
Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Academy of Military Medical Sciences - Institute of Biotechnology, CanSino Biologics Inc., Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Collaborative Innovation Center for Diagnosis Treatment of Infectious Diseases - National Immunization Program, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Academy of Military Medical Sciences - Institute of Biotechnology, Harbin Medical University - Chinese Center for Disease Control and Prevention, Academy of Military Medical Sciences - Institute of Biotechnology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Government of the People's Republic of China - Center of Disease Control and Prevention, Chongqing Center for Disease Control and Prevention, Nanjing Medical University - School of Public Health, Anhui Provincial Center for Disease Control and Prevention, Chongqing Center for Disease Control and Prevention, Anhui Provincial Center for Disease Control and Prevention, Yunan Provincial Center for Disease Control and Prevention, Hunan Provincial Center for Disease Control and Prevention, Anhui Provincial Center for Disease Control and Prevention, Hunan Provincial Center for Disease Control and Prevention, Yunan Provincial Center for Disease Control and Prevention, CanSino Biologics Inc., Nanjing Medical University - Department of Epidemiology and Biostatistics, Academy of Military Medical Sciences - Institute of Biotechnology and Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology
Downloads 111 (454,535)

Abstract:

Loading...

Safety, Immunogenicity, Long-term efficacy, Aerosolized Ad5-nCoV, Booster

7.

Safety and Immunogenicity of Heterologous Boosting With a Protein-Subunit-Based COVID-19 Vaccine (ZF2001) in Healthy Adults Previously Received One Dose of Convidecia: A Randomised, Observer-Blinded, Placebo-Controlled Trial

Number of pages: 36 Posted: 10 Jan 2022
Collaborative Innovation Center for Diagnosis Treatment of Infectious Diseases - NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Anhui Zhifei Longcom Biopharmaceutical Co. LTD., Collaborative Innovation Center for Diagnosis Treatment of Infectious Diseases - Guanyun County Center for Disease Control and Prevention, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Chinese Academy of Sciences (CAS) - CAS Key Laboratory of Pathogenic Microbiology and Immunology, Nanjing Vazyme Biotech Co., Ltd., Collaborative Innovation Center for Diagnosis Treatment of Infectious Diseases - Guanyun County Center for Disease Control and Prevention, Southeast University, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Nanjing Vazyme Biotech Co., Ltd., Anhui Zhifei Longcom Biopharmaceutical Co. LTD., Chinese Academy of Sciences (CAS) - CAS Key Laboratory of Pathogenic Microbiology and Immunology, Anhui Zhifei Longcom Biopharmaceutical Co. LTD., Nanjing Medical University, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology and Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology
Downloads 97 (499,319)

Abstract:

Loading...

SARS-CoV-2, heterologous immunisation, recombinant adenovirus type-5-vectored COVID-19 vaccine, protein-subunit-based COVID-19 vaccine, clinical trial

8.

Sensitivity, Specificity and Safety of a Novel Skin Test (ESAT6-CFP10) for Tuberculosis Infection in China: Randomized, Blinded, Self-Controlled, Parallel-Group Phase 2b Trials

Number of pages: 34 Posted: 16 Mar 2020
Government of the People's Republic of China - National Institutes for Food and Drug Control, Collaborative Innovation Center for Diagnosis Treatment of Infectious Diseases - Jiangsu Provincial Center for Disease Control and Prevention, Fudan University - Shanghai Public Health Clinical Center, Collaborative Innovation Center for Diagnosis Treatment of Infectious Diseases - Jiangsu Provincial Center for Disease Control and Prevention, Government of the People's Republic of China - National Institutes for Food and Drug Control, Tianjin Haihe Hospital, Collaborative Innovation Center for Diagnosis Treatment of Infectious Diseases - Jiangsu Provincial Center for Disease Control and Prevention, Wuhan Institute for Tuberculosis Control - Wuhan Pulmonary Hospital, Government of the People's Republic of China - National Institutes for Food and Drug Control, Collaborative Innovation Center for Diagnosis Treatment of Infectious Diseases - Jiangsu Provincial Center for Disease Control and Prevention, Fudan University - Shanghai Public Health Clinical Center, Collaborative Innovation Center for Diagnosis Treatment of Infectious Diseases - Jiangsu Provincial Center for Disease Control and Prevention, Government of the People's Republic of China - National Institutes for Food and Drug Control, Anhui Zhifei Longcom Biopharmaceutical Co. LTD., Zhejiang Provincial Center for Disease Control and Prevention, Fudan University - Shanghai Public Health Clinical Center, Collaborative Innovation Center for Diagnosis Treatment of Infectious Diseases - Center for Disease Control and Prevention of Jurong city, Tianjin Haihe Hospital, Wuhan Institute for Tuberculosis Control - Department of Pulmonary and Critical care Medicine, Anhui Zhifei Longcom Biopharmaceutical Co. LTD., Fudan University - Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Government of the People's Republic of China - National Institutes for Food and Drug Control and Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology
Downloads 56 (678,398)
Citation 1

Abstract:

Loading...